You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽諾醫療(688108.SH):2024年淨利潤152.11萬元 同比扭虧
格隆匯 02-26 15:48

格隆匯2月26日丨賽諾醫療(688108.SH)公佈2024年度業績快報報告期內,公司實現營業總收入45,873.93萬元,較上年同期增長33.64%;實現歸屬於母公司所有者的淨利潤152.11萬元,較上年同期增長103.84%;實現歸屬於母公司所有者的扣除非經常性損益的淨利潤-1,750.65萬元,較上年同期增長64.79%。本報告期公司較上年同期大幅減虧,主要系營業收入同比較大幅度增長,營業成本、銷售費用及研發費用同比增長,但增長幅度均小於營業收入增長幅度,併疊加管理費用同比小幅下降以及資產減值損失同比大幅增長等因素影響,致使本報告期歸屬於上市公司股東的淨利潤較上年同期相比出現較大幅度增長,同比增長103.84%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account